Cancer in the Upper Aerodigestive Tract (UADT) is still among the leading cancer types worldwide, with both incidence rate and mortality rate constantly rising. Treatment of these diseases is by Ear-Nose-Throat (ENT) surgeons, operating with incomplete knowledge of the tumor geometry, under non-ergonomic conditions and with limited precision on fragile cancerous tissue. AIRCARE’s mission is to transform the care of UADT diseases by integrating advanced AI and robotic technology into clinical workflows.

Specifically, AIRCARE aims to develop and validate two integrated clinical systems (one for diagnosis, one for surgery) comprising AI and robotic systems that have shown promising results in pre-clinical R&D work. This shall generate the necessary evidence to support the uptake and regular clinical use of these technologies as the next standard-of-care in ENT (Ear, Nose and Throat) cancer centers, promoting better patient management and improving clinical outcomes. 

AIRCARE s a collaborative effort involving leading European universities, research institutions, hospitals, medical technology companies and SMEs from across Europe funded by the Horizon Europe program. 
 

Timelex is the legal partner in this four-year project, supporting the AIRCARE consortium in monitoring compliance with Data Protection Laws. Timelex also provides support on regulatory affairs, and contributes in preparation of the documentation needed for approval of the clinical studies and clinical trials.

More information about the AIRCARE project can be found of the project website: https://aircareproject.eu/ and the project page on the CORDIS website: https://cordis.europa.eu/project/id/101137426